ACR PRACTICE PARAMETER FOR THE PERFORMANCE OF MOLECULAR BREAST IMAGING (MBI) USING A DEDICATED GAMMA CAMERA

PREAMBLE

INTRODUCTION

II.

INDICATIONS AND CONTRAINDICATIONS

II.

INDICATIONS AND CONTRAINDICATIONS

Indications

Breast Cancer Screening

II.

INDICATIONS AND CONTRAINDICATIONS

Indications

Extent of Disease

II.

INDICATIONS AND CONTRAINDICATIONS

Indications

Evaluation of Response to Neoadjuvant Chemotherapy

II.

INDICATIONS AND CONTRAINDICATIONS

Indications

Additional Evaluation of Clinical or Imaging Findings

II.

INDICATIONS AND CONTRAINDICATIONS

Indications

Metastatic Axillary Lymphadenopathy of Unknown Primary

II.

INDICATIONS AND CONTRAINDICATIONS

Indications

Lesion Characterization

II.

INDICATIONS AND CONTRAINDICATIONS

Contraindications

III.

QUALIFICATIONS AND RESPONSIBILITIES OF PERSONNEL

IV.

SPECIFICATIONS OF THE EXAMINATION

IV.

SPECIFICATIONS OF THE EXAMINATION

Radiopharmaceuticals

IV.

SPECIFICATIONS OF THE EXAMINATION

Patient Factors

IV.

SPECIFICATIONS OF THE EXAMINATION

Images

DOCUMENTATION

VI.

RADIATION DOSIMETRY

VII.

EQUIPMENT SPECIFICATIONS

VIII.

RADIATION SAFETY IN IMAGING

IX.

QUALITY CONTROL AND IMPROVEMENT, SAFETY, INFECTION CONTROL, AND PATIENT EDUCATION

ACKNOWLEDGEMENTS

REFERENCES

1. Hruska CB, Phillips SW, Whaley DH, Rhodes DJ, O'Connor MK. Molecular breast imaging: use of a dual-head dedicated gamma camera to detect small breast tumors. AJR Am J Roentgenol. 2008 Dec;191(6):1805-15.
2. Hruska CB, Rhodes DJ, Collins DA, Tortorelli CL, Askew JW, O'Connor MK. Evaluation of molecular breast imaging in women undergoing myocardial perfusion imaging with Tc-99m sestamibi. J Womens Health (Larchmt). 2012 Jul;21(7):730-8.
3. Rhodes DJ, Hruska CB, Conners AL, et al. Journal club: molecular breast imaging at reduced radiation dose for supplemental screening in mammographically dense breasts. AJR. American Journal of Roentgenology. 204(2):241-51, 2015 Feb.
4. Rhodes DJ, Hruska CB, Phillips SW, Whaley DH, O'Connor MK. Dedicated dual-head gamma imaging for breast cancer screening in women with mammographically dense breasts. Radiology. 2011;258(1):106-118.
5. Shermis RB, Wilson KD, Doyle MT, et al. Supplemental Breast Cancer Screening With Molecular Breast Imaging for Women With Dense Breast Tissue. AJR. American Journal of Roentgenology. 207(2):450-7, 2016 Aug.
6. Shermis RB, Redfern RE, Burns J, Kudrolli H. Molecular Breast Imaging in Breast Cancer Screening and Problem Solving. Radiographics. 37(5):1309-1606, 2017 Sep-Oct.Radiographics. 37(5):1309-1606, 2017 Sep-Oct.
7. Dieckens D, Lavalaye J, Romijn L, Habraken J. Contrast-noise-ratio (CNR) analysis and optimisation of breast-specific gamma imaging (BSGI) acquisition protocols. EJNMMI Res. 2013 Mar 25;3(1):21.
8. Hruska CB, Weinmann AL, Tello Skjerseth CM, et al. Proof of concept for low-dose molecular breast imaging with a dual-head CZT gamma camera. Part II. Evaluation in patients. Med Phys. 2012 Jun;39(6):3476-83.
9. Kuhn KJ, Rapelyea JA, Torrente J, Teal CB, Brem RF. Comparative Diagnostic Utility of Low-Dose Breast-Specific Gamma Imaging to Current Clinical Standard. Breast J. 2016;22(2):180-8.
10. O'Connor M, Rhodes D, Hruska C. Molecular breast imaging. Expert Rev Anticancer Ther. 2009 Aug;9(8):1073-80.
11. Sun Y, Wei W, Yang HW, Liu JL. Clinical usefulness of breast-specific gamma imaging as an adjunct modality to mammography for diagnosis of breast cancer: a systemic review and meta-analysis. Eur J Nucl Med Mol Imaging 2013;40:450-63.
12. Zhang A, Li P, Liu Q, Song S. Breast-specific gamma camera imaging with 99mTc-MIBI has better diagnostic performance than magnetic resonance imaging in breast cancer patients: A meta-analysis. Hell J Nucl Med. 2017;20(1):26-35.
13. Berg WA, Blume JD, Cormack JB, et al. Combined screening with ultrasound and mammography vs mammography alone in women at elevated risk of breast cancer. JAMA. 2008;299(18):2151-2163.
14. Berg WA, Gutierrez L, NessAiver MS, et al. Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology. 2004; 233(3):830-849.
15. Kim BS, Moon BI, Cha ES. A comparative study of breast-specific gamma imaging with the conventional imaging modality in breast cancer patients with dense breasts. Ann Nucl Med. 2012 Dec;26(10):823-9.
16. Lee A, Chang J, Lim W, et al. Effectiveness of breast-specific gamma imaging (BSGI) for breast cancer in Korea: a comparative study. Breast J. 2012 Sep;18(5):453-8.
17. Taillefer R. The role of 99mTc-sestamibi and other conventional radiopharmaceuticals in breast cancer diagnosis. Semin Nucl Med. 1999 Jan;29(1):16-40.
18. Mainiero MB, Lourenco A, Mahoney MC, et al. ACR Appropriateness Criteria Breast Cancer Screening. J Am Coll Radiol. 2013 Jan;10(1):S1546-1440(12)00682-5.
19. Berg WA, Zhang Z, Lehrer D, et al. Detection of breast cancer with addition of annual screening ultrasound or a single screening MRI to mammography in women with elevated breast cancer risk. JAMA. 307(13):1394-404, 2012 Apr 04.
20. Friedewald SM, Rafferty EA, Rose SL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography. JAMA. 311(24):2499-507, 2014 Jun 25.
21. Gur D, Abrams GS, Chough DM, et al. Digital breast tomosynthesis: observer performance study. AJR Am J Roentgenol. 2009 Aug;193(2):586-91.
22. American College of Radiology. ACR Practice Parameter for the Performance of Contrast-Enhanced Magnetic Resonance Imaging (MRI) of the Breast. Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=6+&releaseId=2
23. Berg WA, Blume JD, Adams AM, et al. Reasons women at elevated risk of breast cancer refuse breast MR imaging screening: ACRIN 6666. Radiology. 2010 Jan;254(1):79-87.
24. Houssami N, Ciatto S, Macaskill P, et al. Accuracy and surgical impact of magnetic resonance imaging in breast cancer staging: systematic review and meta-analysis in detection of multifocal and multicentric cancer. J Clin Oncol. 2008;26(19):3248-3258.
25. Edwards C, Williams S, McSwain AP, et al. Breast-specific gamma imaging influences surgical management in patients with breast cancer. Breast J. 2013;19(5):512-9.
26. Berg WA, Rafferty EA, Friedewald SM, Hruska CB, Rahbar H. Screening Algorithms in Dense Breasts: AJR Expert Panel Narrative Review. [Review]. AJR. American Journal of Roentgenology. 216(2):275-294, 2021 02.
27. Hruska CB, Geske JR, Swanson TN, et al. Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study. Breast Cancer Research. 20(1):46, 2018 06 05.
28. Lee SJ, Choi YY, Kim C, Chung MS. Correlations between Tumor to Background Ratio on Breast-Specific Gamma Imaging and Prognostic Factors in Breast Cancer. J Korean Med Sci. 2017 Jun;32(6):1031-1037.
29. Killelea BK, Gillego A, Kirstein LJ, et al. George Peters Award: How does breast-specific gamma imaging affect the management of patients with newly diagnosed breast cancer?. Am J Surg. 2009 Oct;198(4):470-4.
30. Kim BS.. Usefulness of breast-specific gamma imaging as an adjunct modality in breast cancer patients with dense breast: a comparative study with MRI. Ann Nucl Med. 26(2):131-7, 2012 Feb.
31. Zhou M, Johnson N, Gruner S, et al. Clinical utility of breast-specific gamma imaging for evaluating disease extent in the newly diagnosed breast cancer patient. Am J Surg. 2009 Feb;197(2):159-63.
32. Johnson N, Sorenson L, Bennetts L, et al. Breast-specific gamma imaging is a cost effective and efficacious imaging modality when compared with MRI. Am J Surg. 2014 May;207(5):S0002-9610(14)00081-6.
33. Sumkin JH, Berg WA, Carter GJ, et al. Diagnostic Performance of MRI, Molecular Breast Imaging, and Contrast-enhanced Mammography in Women with Newly Diagnosed Breast Cancer. Radiology. 293(3):531-540, 2019 12.
34. Rauch GM, Adrada BE. Comparison of Breast MR Imaging with Molecular Breast Imaging in Breast Cancer Screening, Diagnosis, Staging, and Treatment Response Evaluation. [Review]. Magn Reson Imaging Clin N Am. 26(2):273-280, 2018 May.
35. Brem RF, Ioffe M, Rapelyea JA, et al. Invasive lobular carcinoma: detection with mammography, sonography, MRI, and breast-specific gamma imaging. AJR Am J Roentgenol. 2009 Feb;192(2):379-83.
36. Yoo J, Kim BS, Yoon HJ. Predictive significance of breast-specific gamma imaging for upstaging core-needle biopsy-detected ductal carcinoma in situ to invasive cancer. Annals of Nuclear Medicine. 32(5):328-336, 2018 Jun.
37. Hayward JH, Linden OE, Lewin AA, et al. ACR Appropriateness Criteria R Monitoring Response to Neoadjuvant Systemic Therapy for Breast Cancer: 2022 Update. Journal of the American College of Radiology. 20(5S):S125-S145, 2023 05.
38. Hylton NM, Blume JD, Bernreuter WK, et al. Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy--results from ACRIN 6657/I-SPY TRIAL. Radiology. 263(3):663-72, 2012 Jun.
39. Jochelson MS, Lampen-Sachar K, Gibbons G, et al. Do MRI and mammography reliably identify candidates for breast conservation after neoadjuvant chemotherapy?. Ann Surg Oncol. 22(5):1490-5, 2015 May.
40. Marinovich ML, Houssami N, Macaskill P, et al. Meta-analysis of magnetic resonance imaging in detecting residual breast cancer after neoadjuvant therapy. [Review]. J Natl Cancer Inst. 105(5):321-33, 2013 Mar 06.
41. Lu WL, Jansen L, Post WJ, Bonnema J, Van de Velde JC, De Bock GH. Impact on survival of early detection of isolated breast recurrences after the primary treatment for breast cancer: a meta-analysis. Breast Cancer Res Treat 2009;114:403-12.
42. Hunt KN, Conners AL, Goetz MP, et al. Comparison of 99mTc-Sestamibi Molecular Breast Imaging and Breast MRI in Patients With Invasive Breast Cancer Receiving Neoadjuvant Chemotherapy. AJR Am J Roentgenol. 213(4):932-943, 2019 10.
43. Kolasinska AD, Buscombe JR, Cwikla JB, et al. The role of scintimammography and mammography in recurrent breast cancer. Evaluation of their accuracy using ROC curves. Nucl Med Rev Cent East Eur. 2001;4(2):77-82.
44. Orel SG, Weinstein SP, Schnall MD, et al. Breast MR imaging in patients with axillary node metastases and unknown primary malignancy. Radiology. 1999 Aug;212(2):543-9.
45. Collarino A, de Koster EJ, Valdes Olmos RA, de Geus-Oei LF, Pereira Arias-Bouda LM. Is Technetium-99m Sestamibi Imaging Able to Predict Pathologic Nonresponse to Neoadjuvant Chemotherapy in Breast Cancer? A Meta-analysis Evaluating Current Use and Shortcomings. Clin Breast Cancer. 18(1):9-18, 2018 02.
46. Drew PJ, Kerin MJ, Turnbull LW, et al. Routine screening for local recurrence following breast-conserving therapy for cancer with dynamic contrast-enhanced magnetic resonance imaging of the breast. Ann Surg Oncol. 1998;5(3):265-70.
47. Nunes LW, Schnall MD, Orel SG. Update of breast MR imaging architectural interpretation model. Radiology. 2001 May;219(2):484-94.
48. Schnall MD, Blume J, Bluemke DA, et al. Diagnostic architectural and dynamic features at breast MR imaging: multicenter study. Radiology. 2006 Jan;238(1):42-53.
49. Brennan S, Liberman L, Dershaw DD, Morris E. Breast MRI screening of women with a personal history of breast cancer. AJR Am J Roentgenol. 2010;195(2):510-516.
50. Cwikla JB, Kolasinska A, Buscombe JR, Hilson AJ. Tc-99m MIBI in suspected recurrent breast cancer. Cancer Biother Radiopharm. 2000 Aug;15(4):367-72.
51. Siegal E, Angelakis E, Morris P, Pinkus E. Breast molecular imaging: a retrospective review of one institutions experience with this modality and analysis of its potential role in breast imaging decision making. Breast J. 2012;18(2):111-7.
52. Weigert JM, Bertrand ML, Lanzkowsky L, Stern LH, Kieper DA. Results of a multicenter patient registry to determine the clinical impact of breast-specific gamma imaging, a molecular breast imaging technique. AJR Am J Roentgenol. 2012 Jan;198(1):W69-75.
53. Huppe AI, Mehta AK, Brem RF. Molecular Breast Imaging: A Comprehensive Review. [Review]. Seminars in Ultrasound, CT & MR. 39(1):60-69, 2018 Feb.Semin Ultrasound CT MR. 39(1):60-69, 2018 Feb.
54. Adrada BE, Moseley T, Kappadath SC, Whitman GJ, Rauch GM. Molecular Breast Imaging-guided Percutaneous Biopsy of Breast Lesions: A New Frontier on Breast Intervention. Journal of Breast Imaging. 2(5):484-491, 2020 Sep-Oct.J Breast Imaging. 2(5):484-491, 2020 Sep-Oct.
55. Vlahiotis A, Griffin B, Stavros AT, Margolis J. Analysis of utilization patterns and associated costs of the breast imaging and diagnostic procedures after screening mammography. Clinicoecon Outcomes Res. 2018;10():157-167.
56. Brem RF, Mehta AK, Rapelyea JA, Akin EA, Bazoberry AM, Velasco CD. Gamma Imaging-Guided Minimally Invasive Breast Biopsy: Initial Clinical Experience. AJR Am J Roentgenol. 210(3):695-699, 2018 Mar.
57. American College of Radiology. ACR-SPR Practice Parameter for Imaging Pregnant or Potentially Pregnant Patients with Ionizing Radiation. Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=23+&releaseId=2.
58. Nyakale N, Lockhat Z, Sathekge M. Nuclear medicine-induced allergic reactions. Curr Allergy Immunol 2015;28:10-17.
59. Silberstein EB, Ryan J. Prevalence of adverse reactions in nuclear medicine. Pharmacopeia Committee of the Society of Nuclear Medicine. J Nucl Med. 1996 Jan;37(1):185-92.
60. American College of Radiology. ACR Practice Parameter for the Performance of Screening and Diagnostic Mammography. Available at: https://gravitas.acr.org/PPTS/GetDocumentView?docId=8+&releaseId=2
61. American College of Radiology. ACR accreditation nuclear medicine and PET program requirements. Available at: https://www.acraccreditation.org/modalities/nuclear-medicine-and-pet.
62. American College of Radiology. ACR Practice Parameter for Continuing Medical Education. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=130+&releaseId=2
63. American College of Radiology. ACR–AAPM–SIIM Practice Parameter for Determinants of Image Quality in Mammography. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=140+&releaseId=2
64. American College of Radiology. ACR–AAPM Technical Standard for Nuclear Medical Physics Performance Monitoring of Gamma Cameras. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=196+&releaseId=2
65. American College of Radiology. ACR–ACNM–SNMMI–SPR Practice Parameter for the Use of Radiopharmaceuticals in Diagnostic Procedures. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=171+&releaseId=2
66. Manapragada PP. Molecular Imaging in Management of Breast Cancer. Semin Roentgenol. 2018 Oct;53(4):S0037-198X(18)30071-3.
67. Muzahir S. Molecular Breast Cancer Imaging in the Era of Precision Medicine. AJR Am J Roentgenol. 2020 Dec;215(6):1512-1519.
68. Swanson T, Tran TD, Ellingson L, et al. BEST PRACTICES IN MOLECULAR BREAST IMAGING: A GUIDE FOR TECHNOLOGISTS. J Nucl Med Technol. 2018 Feb 02;():jnmt.117.204263.
69. O'Connor MK, Li H, Rhodes DJ, Hruska CB, Clancy CB, Vetter RJ. Comparison of radiation exposure and associated radiation-induced cancer risks from mammography and molecular imaging of the breast. Med Phys. 2010;37(12):6187-6198.
70. Tran TD, Ellingson LR, Swanson TN, Solberg CM, O'Connor MK, Hruska CB. Molecular Breast Imaging: Administered Activity Does Not Require Adjustment Based on Patient Size. J Nucl Med Technol. 2018 Sep;46(3):265-267.
71. O'Connor MK, Hruska CB, Tran TD, et al. Factors influencing the uptake of 99mTc-sestamibi in breast tissue on molecular breast imaging. J Nucl Med Technol. 2015 Mar;43(1):13-20.
72. American College of Radiology. ACR Practice Parameter for Communication of Diagnostic Imaging Findings. Available at https://gravitas.acr.org/PPTS/GetDocumentView?docId=74+&releaseId=2
73. Conners AL, Hruska CB, Tortorelli CL, et al. Lexicon for standardized interpretation of gamma camera molecular breast imaging: observer agreement and diagnostic accuracy. Eur J Nucl Med Mol Imaging. 2012 Jun;39(6):971-82.
74. Ching JG, Brem RF. Breast Lesions Detected via Molecular Breast Imaging: Physiological Parameters Affecting Interpretation. Acad Radiol. 2018 Dec;25(12):S1076-6332(18)30116-8.
75. Choi EK, Im JJ, Park CS, Chung YA, Kim K, Oh JK. Usefulness of feature analysis of breast-specific gamma imaging for predicting malignancy. European Radiology. 28(12):5195-5202, 2018 Dec.
76. Dibble EH, Hunt KN, Ehman EC, O'Connor MK. Molecular Breast Imaging in Clinical Practice. AJR Am J Roentgenol. 2020 Aug;215(2):277-284.
77. Cardiolite® Kit for the preparation of technetium Tc99m sestamibi for injection 513121-1007. Available at: http://www.accessdata.fda.gov/drugsatfda_docs/label/2008/019785s018lbl.pdf.
78. Nardinger SM, Tran TD, Swanson TN, et al. Guidelines for Quality Control Testing of Molecular Breast Imaging Systems. Journal of Nuclear Medicine Technology. 46(4):349-354, 2018 Dec.J Nucl Med Technol. 46(4):349-354, 2018 Dec.